Brainsway reports positive trial results for blepharospasm treatment

01/20/2008 | Globes (Israel)

Brainsway Ltd. said its transcranial magnetic stimulation treatment has proven effective in the treatment of involuntary blinking, also known as blepharospasm, in a Phase IIa trial. Trial results suggest that the treatment could improve hyperexcitability of the brain stem, the company said.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC